Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
- Status
- RECRUITING
- Phase
- N/A
Measuring Oncological Value of Exercise and Statin
- Status
- RECRUITING
- Phase
- PHASE3
Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Discovering Factors in Metastatic Breast Cancer Patients' Clinical Trial Experiences
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+Pertuzumab
- Status
- TERMINATED
- Phase
- PHASE2
Liquid Biopsy: Intercepting Mutational Trajectories of HER2 (Human Epidermal Growth Factor Receptor 2) Breast Cancer (GIM21 Trial)
- Status
- COMPLETED
- Phase
- NA
Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
STOP-HER2: Stopping Trastuzumab in HER2+ MBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
- Status
- RECRUITING
- Phase
- PHASE2
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
- Status
- RECRUITING
- Phase
- PHASE2
Assessing the Time Demands of Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701
- Status
- WITHDRAWN
- Phase
- PHASE2
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- Status
- RECRUITING
- Phase
- PHASE3